Macimorelin
Also known as: AEZS-130 · Macrilen
An FDA-approved oral ghrelin receptor agonist used as a diagnostic tool for adult growth hormone deficiency.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~4–6 hours
0.5 mg/kg single oral dose (diagnostic)
Oral
Mechanism of Action
Orally bioavailable ghrelin mimetic that triggers measurable GH spike within 60 minutes, enabling non-invasive GH deficiency diagnosis.
Key Research Areas
Frequently Asked Questions
What is Macimorelin?▾
How does Macimorelin work?▾
What is the recommended dosage for Macimorelin?▾
What is the half-life of Macimorelin?▾
Is Macimorelin FDA approved?▾
Ready to get started with Macimorelin?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Macimorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.